ScholarDeck

Cohort studyJournal of the Society for Cardiovascular Angiography & Interventions · 2026

Pulmonary Embolism in the United States: A Report From the National PERT Consortium.

William Brent Keeling, Steven Horbal, Kenneth Rosenfield … Eric A Secemsky

Read paper

Internal MedicineCohort study

One-year survival was only 67.8% for patients with high-risk pulmonary embolism.

Pulmonary Embolism in the United States: A Report From the National PERT Consortium.

William Brent Keeling … Eric A Secemsky

Journal of the Society for Cardiovascular Angiography & Interventions · 2026

Background

Pulmonary embolism (pulmonary embolism) remains the third leading cause of cardiovascular-related mortality, and few efforts have been made to study it exclusively through real-world registry data.

Methods

All patients were assigned a pulmonary embolism-specific risk stratification score based on available data.

n = 3 patients

Results

one-year survival was far worse than the intermediate-risk group's, roughly one in three died

30-day survival (cathe

95.1%

1-year survival (cathe

92.3%

1-year survival (high-

67.8%

More results

Patients tended to be slightly obese (mean body mass index, 31.1 kg/m 2 ) and were more frequently men (51.1%).

A patient history of deep vein thrombosis was observed in 1 in 3 patients, and 1 in 4 had a history of malignancy.

Furthermore, patients with pulmonary embolism on average spent 4 days in the hospital.

More results

When evaluating survival by treatment types, 30-day and 1-year survival in patients who underwent catheter-based intervention were 95.1% and 92.3%, respectively.

“

Conclusion · 1 of 2

Real-world data from the National PERT Consortium database demonstrate current practices in the care of patients with pulmonary embolism.

Conclusion · 2 of 2

Opportunities exist for better risk stratification and improvement in care across the spectrum of pulmonary embolism.

Post

Pulmonary Embolism in the United States: A Report From the National PERT Consortium.

One-year survival was only 67.8% for patients with high-risk pulmonary embolism.

Related papers